Immune System News and Research

RSS

New findings from STELARA psoriasis clinical trial to be presented at 22nd World Congress of Dermatology

New findings to be presented from pooled analyses of the STELARA psoriasis clinical development program showed that the safety profile of STELARA and rates of adverse events remained consistent and stable over time in adults with moderate to severe plaque psoriasis receiving up to four years of treatment.

25 May 2011

Idera Pharmaceuticals' preclinical data on novel GSO technology presented at TIDES 2011

Idera Pharmaceuticals, Inc. today announced the presentation of preclinical data of its novel gene-silencing oligonucleotide technology including observations that demonstrate GSOs exert gene-silencing activity through a similar cellular pathway as siRNA.

25 May 2011

Recent ACS podcast focuses on new rapid blood test that can detect MRSA infections

The latest episode in the American Chemical Society's award-winning podcast series, "Global Challenges/Chemistry Solutions," focuses on new blood test that can quickly tell whether patients are infected with an antibiotic-resistant bacterium that's become a global threat, significantly improving treatment.

25 May 2011

Diabetics have higher risk of contracting tuberculosis

People with diabetes have a three to five times higher risk of contracting tuberculosis (TB) than non-diabetics, according to researchers at The University of Texas Health Science Center at Houston.

25 May 2011

Positive interim results from new bladder cancer therapy trial

Clinical trials for a new bladder cancer therapy show promising interim results. Lead researcher Alvaro Morales says that the breakthrough using the drug Urocidin follows thirty years of his research in this important area.

25 May 2011

Scientists develop quick, low-cost microchip for immune monitoring and clinical applications

There's a wealth of health information hiding in the human immune system. Accessing it, however, can be very challenging, as the many and complex roles that the immune system plays can mask the critical information that is relevant to addressing specific health issues.

25 May 2011

MRSA, VRE traces found in bed bugs

Reports of bed bug infestations are on the rise worldwide. Recently, scientists in Canada studying five bed bugs found on patients at St. Paul's Hospital, found traces of methicillin-resistant Staphylococcus aureus, or MRSA, and vancomycin-resistant Enterococcus faecium, or VRE. However as of yet, no evidence indicating that bed bugs can transmit disease to humans has been found.

25 May 2011

Small pox virus destruction pushed back to 2014

The last existing vials of smallpox virus in the U.S. and Russia and due for destruction, have won at least another three years in existence. This is suggesting other countries concur with the U.S. about their value, one leading health official said. The experts and delegates at the annual meeting of the World Health Organization agreed on Tuesday to wait until 2014 to decide on a firm deadline for the final destruction of the lethal virus.

24 May 2011

Scientists mimic dyskeratosis congenita through study of undifferentiated iPS cells

A rare genetic disease called dyskeratosis congenita, caused by the rapid shortening of telomeres, can be mimicked through the study of undifferentiated induced pluripotent stem cells, according to new findings from the Stanford University School of Medicine.

24 May 2011

Accelerator announces Series A financing of Oncofactor

Accelerator Corporation, a privately held, venture-capital-backed biotechnology investment and development company, announced today the Series A financing of Oncofactor Corporation. This is the twelfth company backed by Accelerator and its first investment based on internal intellectual property developed at Accelerator.

24 May 2011

Study offers hope for reducing incidence of AIDS with potential preventive vaccine

The HIV epidemic is the largest in the world and represents one of the most serious public health problems, according to data from the World Health Organization. Only 30% of the more than 10 million patients in need have the access to the antiretroviral treatment.

24 May 2011

Scientific evidence supports benefits of sunscreen usage to prevent skin cancer

The American Academy of Dermatology today reiterated the safety and effectiveness of sunscreens to protect against the damaging effects from exposure to ultraviolet (UV) radiation. As one component of a daily sun-protection strategy, sunscreen is an important tool in the fight against skin cancer, including melanoma, the deadliest form of skin cancer.

24 May 2011

NIAID team completes analysis of most proteins produced by elephantiasis parasite worm

A team led by Thomas B. Nutman, M.D., of the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, has completed a large-scale analysis of most of the proteins produced by Brugia malayi, one kind of parasitic worm that causes lymphatic filariasis, or elephantiasis.

24 May 2011

Fluorinated glucosamine blocks synthesis of key sugar linked to skin inflammation, cancer progression

Charles J. Dimitroff, MS, PhD and colleagues in the Dimitroff Lab at Brigham and Women's Hospital, have developed a fluorinated analog of glucosamine, which, in a recent study, has been shown to block the synthesis of key carbohydrate structures linked to skin inflammation and cancer progression. These findings appear in the April 14, 2011, issue of the Journal of Biological Chemistry.

24 May 2011

Research could pave way toward new anti-bacterial treatments

A group of proteins that act as the body's built-in line of defense against invading bacteria use a molecular trick to induce bacteria to destroy themselves, researchers at the Indiana University School of Medicine have determined. The research could point the way toward new anti-bacterial treatments that could take on bacteria that are resistant to antibiotics.

24 May 2011

VBL to present updated VB-111 Phase 1 trial results in advanced metastatic cancer at ASCO 2011

VBL Therapeutics, a clinical-stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced that it will present updated results for a Phase 1 study of VB-111 in patients with advanced metastatic cancer at the upcoming Annual Meeting of the American Society of Clinical Oncology, taking place June 3-7, 2011, at McCormick Place in Chicago.

24 May 2011

Probiotic bacterial protein could offer new oral therapeutic option for inflammatory bowel disorders

A protein isolated from beneficial bacteria found in yogurt and dairy products could offer a new, oral therapeutic option for inflammatory bowel disorders, suggests a study led by Vanderbilt University Medical Center researcher Fang Yan, M.D., Ph.D.

24 May 2011

Lund University researcher discovers new sepsis biomarker in blood

Sepsis is the name of an infection that causes a series of reactions in the body, which in the worst case can prove fatal. The problem for both patients and doctors is that the early symptoms are difficult to distinguish from less dangerous infections such as a severe flu or winter vomiting disease.

23 May 2011

H. pylori infection could play a role in Parkinson's disease development

The stomach bacteria responsible for ulcers could also play a role in the development of Parkinson's disease according to research presented today at the 111th General Meeting of the American Society for Microbiology.

23 May 2011

Tumor necrosis factor can suppress inflammation, treat rheumatoid arthritis

A new study by rheumatologists at Hospital for Special Surgery in New York has shown that a powerful pro-inflammatory protein, tumor necrosis factor, can also suppress aspects of inflammation.

23 May 2011

Immune System News and Research

New findings from STELARA psoriasis clinical trial to be presented at 22nd World Congress of Dermatology

Idera Pharmaceuticals' preclinical data on novel GSO technology presented at TIDES 2011

Recent ACS podcast focuses on new rapid blood test that can detect MRSA infections

Diabetics have higher risk of contracting tuberculosis

Positive interim results from new bladder cancer therapy trial

Scientists develop quick, low-cost microchip for immune monitoring and clinical applications

MRSA, VRE traces found in bed bugs

Small pox virus destruction pushed back to 2014

Scientists mimic dyskeratosis congenita through study of undifferentiated iPS cells

Accelerator announces Series A financing of Oncofactor

Study offers hope for reducing incidence of AIDS with potential preventive vaccine

Scientific evidence supports benefits of sunscreen usage to prevent skin cancer

NIAID team completes analysis of most proteins produced by elephantiasis parasite worm

Fluorinated glucosamine blocks synthesis of key sugar linked to skin inflammation, cancer progression

Research could pave way toward new anti-bacterial treatments

VBL to present updated VB-111 Phase 1 trial results in advanced metastatic cancer at ASCO 2011

Probiotic bacterial protein could offer new oral therapeutic option for inflammatory bowel disorders

Lund University researcher discovers new sepsis biomarker in blood

H. pylori infection could play a role in Parkinson's disease development

Tumor necrosis factor can suppress inflammation, treat rheumatoid arthritis

Immunology eBook

Revolutionizing Life Science: An Interview with SCIEX on ASMS, the SCIEX 7500+ System, and AI-Driven Quantitation

From Discovery Biology to ELRIG Chair

Breathing New Life into Diagnostics: Plasmion's SICRIT Technology

Latest News